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Robert D Newman*Abstract
Progress in malaria control over the past decade has been striking, with malaria mortality rates falling by
approximately one quarter globally and more than a third in the World Health Organization African Region. In the
accompanying paper, Cohen et al. demonstrate the potential fragility of these gains, comprehensively describing
malaria resurgences that have occurred over the past 80 or so years. They found that the vast majority of
resurgences were due, at least in part, to the weakening of malaria control programmes; resource constraints were
the most commonly identified factor. Their findings are timely and compelling, demonstrating that global efforts
will be wasted if the required resources are not secured to achieve and maintain universal access to life-saving
malaria prevention and control tools. The greatest threats to current malaria control efforts are not biological, but
financial. The increases in funding for malaria over the past decade, while impressive, still fall far short of the nearly
$6 billion dollars required annually. Domestic spending by endemic country governments on malaria specifically,
and health more generally, could go a long way towards filling the projected funding gap. However, external
funding is also essential, and the global community needs to work together to ensure full funding of the Global
Fund to Fight AIDS, Tuberculosis, and Malaria, which has been the single largest source of malaria funding over the
past decade. This year, on April 25th, World Malaria Day will be celebrated with the theme “Sustain Gains, Save
Lives: Invest in Malaria.” The review by Cohen et al. suggests one possible future if such investment is not made.
However, with sufficient support, malaria resurgences can be relegated to history.
Keywords: Malaria, Resurgence, FinancingOver the past decade, malaria has been reinstated as a
priority for global health investment. International funding
commitments for malaria control have risen from under
$100 million in 2003 to more than $2 billion in 2011[1].
These resources have allowed for the scale-up OF proven
malaria control interventions, including long-lasting in-
secticidal nets (LLINs), indoor residual spraying, diagnos-
tic testing, and treatment with highly efficacious
artemisinin-based combination therapy. As an example,
more than 290 million LLINs were distributed in sub-Sa-
haran Africa between 2008 and the end of 2010 [1].
Concurrent with the dramatic increases in access to
malaria control interventions, malaria cases have fallen
by more than 50% in 43 countries (eight of them in Af-
rica) over the past decade; another eight countries have
registered declines of more than 25% [1]. While many of
these declines occurred in countries with already low
malaria transmission, some have occurred in settingsCorrespondence: newmanr@who.int
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reproduction in any medium, provided the orwith moderate-to-high transmission. Over this same
time period, malaria mortality rates have fallen by ap-
proximately one quarter globally and more than a third
in the WHO African Region [1].
While the progress in malaria control has been striking,
it is frequently described as “fragile”. In the accompanying
paper, Cohen et al. demonstrate just how true this is, com-
prehensively describing malaria resurgences that have oc-
curred over the past 80 or so years [2]. They found that
the vast majority (more than 90%) of resurgences were
due, at least in part, to the weakening of malaria control
programmes; resource constraints were the most com-
monly identified factor. Less than one third of resurgences
were associated with drug or insecticide resistance.
Their findings are timely and compelling. While
addressing Plasmodium resistance to anti-malarial medi-
cines and Anopheles resistance to insecticides are urgent
priorities requiring concerted global action [3,4], such
efforts will be wasted if the required resources are not
secured to achieve and maintain universal access to life-
saving malaria prevention and control tools. The greatest. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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logical, but financial.
The increases in funding for malaria over the past dec-
ade, while impressive, still fall far short of the nearly $6 bil-
lion dollars required annually to ensure universal access
to malaria prevention and control [5]. Despite stable
and significant funding from the United States through
the Presidents Malaria Initiative, and recent substantial
commitments from the UK through the Department for
International Development, the financial projections for
the coming years are concerning. Based on current in-
formation, resources available for global malaria efforts
are projected to remain relatively stable in 2012–2013,
and then decline through 2015 [1].
That downward trend can, however, be reversed. First,
increased domestic spending by endemic country govern-
ments on malaria specifically, and health more generally,
could go a long way towards filling the projected funding
gap. If just 1% of total domestic spending were made avail-
able for malaria control, 75 of the 99 countries with on-
going malaria transmission could raise enough to provide
each person at risk with access to an ITN [1]. Second, the
global community needs to work together to ensure full
funding of the Global Fund to Fight AIDS, Tuberculosis,
and Malaria. The Global Fund has been the single largest
source of malaria funding over the past decade. The fail-
ure to fully replenish the Fund places a decade of progress
at major risk. The cancellation of Round 11, and the lim-
ited pool of funding available through the Transitional
Funding Mechanism, risk causing the very sort of service
interruptions that Cohen at al have identified as being a
primary factor in documented malaria resurgences.
In the case of malaria, the fact that the Global Fund has
not categorized malaria prevention and control interven-
tions as being eligible for Continuity of Services funding,
as is the case for anti-retroviral and anti-tuberculosis med-
icines, medicines to prevent mother to child transmission
of HIV, and opioid substitution therapy, only heightens the
risk of reversing the gains in malaria control following ser-
vice interruptions [6]. The failure to replace an LLIN be-
fore it is worn out places individual lives at risk, especially
as continuous protection against malaria diminishes the ac-
quisition of partial immunity. The failure to replace a co-
hort of LLINs in a timely manner places entire populations
at risk of dramatic resurgences in malaria transmission, as
demonstrated by Cohen et al. [2].
But such population-level reversals are not inevitable.
What Cohen et al. [2] discuss only briefly are the coun-
tries that have successfully controlled or eliminated mal-
aria and then maintained those achievements. Malaysia,
Thailand, and Viet Nam, for example, have substantially
reduced malaria cases and deaths since the early 1990’s
by intensifying and maintaining preventive efforts and
ensuring wide availability of anti-malarial medicines.Reunion and Singapore have been able to maintain their
malaria free status despite a continual risk of importation
[1]. This sort of durable progress is an integral part not
only of reaching ambitious global malaria targets, but of
reaching the health-related Millennium Development
Goals by 2015.
These successes demonstrate that the 43 countries
where malaria cases have fallen by more than half over
the past decade are not doomed to resurgence: malaria
control does work, and the gains can be maintained.
Such progress need not be ephemeral. Accomplishing this,
however, requires continued political and financial com-
mitment not only on the part of donors, but by endemic
countries themselves.
This year, on April 25th, World Malaria Day will be
celebrated with the theme “Sustain Gains, Save Lives:
Invest in Malaria.” The review by Cohen et al. [2] sug-
gests one possible future if such investment is not made.
However, with sufficient support, malaria resurgences
can be relegated to history.
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